@StanfordMed @WinshipAtEmory “Unsilencing” Read the article— BCOR and BCORL1 mutations in #leukemia. https://t.co/pDEbczEcUZ @EvaJohannaScha1 @DanaFarber #ASH23 https://t.co/dzXKIGCBO3
@WinshipAtEmory “Unsilencing” Read the article— BCOR and BCORL1 mutations in #leukemia. https://t.co/pDEbczEcUZ @EvaJohannaScha1 @DanaFarber https://t.co/nW3hhX6Khq
The authors of "BCOR and BCORL1 Mutations Drive Epigenetic Reprogr…" (https://t.co/rvwVzRkAuI) included RRIDs in their paper! We appreciate the author's support of reproducibility. #methodsmatter #accelerateopenscience
RT @BCD_AACR: From the March Issue: BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 fr…
The topic of #AACR22 Major Symposium: How BCOR mutations unsilence PRC1 by @ColemanLindsley, @EvaJohannaScha1 et al. https://t.co/jdmGKhAzeF @DanaFarber https://t.co/t3inljF3UV
RT @humanimmunenews: 📢 New in @BCD_AACR! A study led by Dr. @ColemanLindsley at @DanaFarber reveals a novel #epigenetic mechanism that exp…
RT @BCD_AACR: From the March Issue: BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 fr…
RT @humanimmunenews: 📢 New in @BCD_AACR! A study led by Dr. @ColemanLindsley at @DanaFarber reveals a novel #epigenetic mechanism that exp…
📢 New in @BCD_AACR! A study led by Dr. @ColemanLindsley at @DanaFarber reveals a novel #epigenetic mechanism that explains PRC1.1 tumor-suppressive activity and identifies a therapeutic strategy in PRC1.1-mutated #cancer. Read the study: https://t.co/LMX
RT @_TanyaBondar_: Unsilencing: oncogenic signaling gets loud when there's no BCOR around!
Unsilencing: oncogenic signaling gets loud when there's no BCOR around!
RT @BCD_AACR: From the March Issue: BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 fr…
From the March Issue: BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes by Schaefer, @ColemanLindsley et al. https://t.co/5Ou5MUj7kV @DanaFarber #epigenetics #leusm https://t.co/CtV9GjnXb
RT @ColemanLindsley: Our latest in @BCD_AACR BCOR-PRC1.1 mutations are common in #leukemia and linked to secondary AML w poor outcomes. Ho…
RT @ColemanLindsley: Our latest in @BCD_AACR BCOR-PRC1.1 mutations are common in #leukemia and linked to secondary AML w poor outcomes. Ho…
RT @ColemanLindsley: Our latest in @BCD_AACR BCOR-PRC1.1 mutations are common in #leukemia and linked to secondary AML w poor outcomes. Ho…
RT @ColemanLindsley: Our latest in @BCD_AACR BCOR-PRC1.1 mutations are common in #leukemia and linked to secondary AML w poor outcomes. Ho…
RT @ColemanLindsley: Our latest in @BCD_AACR BCOR-PRC1.1 mutations are common in #leukemia and linked to secondary AML w poor outcomes. Ho…
RT @ColemanLindsley: Our latest in @BCD_AACR BCOR-PRC1.1 mutations are common in #leukemia and linked to secondary AML w poor outcomes. Ho…
RT @ColemanLindsley: Our latest in @BCD_AACR BCOR-PRC1.1 mutations are common in #leukemia and linked to secondary AML w poor outcomes. Ho…
RT @ColemanLindsley: Our latest in @BCD_AACR BCOR-PRC1.1 mutations are common in #leukemia and linked to secondary AML w poor outcomes. Ho…
RT @ColemanLindsley: Our latest in @BCD_AACR BCOR-PRC1.1 mutations are common in #leukemia and linked to secondary AML w poor outcomes. Ho…
RT @ColemanLindsley: Our latest in @BCD_AACR BCOR-PRC1.1 mutations are common in #leukemia and linked to secondary AML w poor outcomes. Ho…
RT @ColemanLindsley: Our latest in @BCD_AACR BCOR-PRC1.1 mutations are common in #leukemia and linked to secondary AML w poor outcomes. Ho…
RT @ColemanLindsley: Our latest in @BCD_AACR BCOR-PRC1.1 mutations are common in #leukemia and linked to secondary AML w poor outcomes. Ho…
RT @ColemanLindsley: Our latest in @BCD_AACR BCOR-PRC1.1 mutations are common in #leukemia and linked to secondary AML w poor outcomes. Ho…
RT @ColemanLindsley: Our latest in @BCD_AACR BCOR-PRC1.1 mutations are common in #leukemia and linked to secondary AML w poor outcomes. Ho…
RT @ColemanLindsley: Our latest in @BCD_AACR BCOR-PRC1.1 mutations are common in #leukemia and linked to secondary AML w poor outcomes. Ho…
RT @ColemanLindsley: Our latest in @BCD_AACR BCOR-PRC1.1 mutations are common in #leukemia and linked to secondary AML w poor outcomes. Ho…
RT @ColemanLindsley: Our latest in @BCD_AACR BCOR-PRC1.1 mutations are common in #leukemia and linked to secondary AML w poor outcomes. Ho…
RT @ColemanLindsley: Our latest in @BCD_AACR BCOR-PRC1.1 mutations are common in #leukemia and linked to secondary AML w poor outcomes. Ho…
RT @ColemanLindsley: Our latest in @BCD_AACR BCOR-PRC1.1 mutations are common in #leukemia and linked to secondary AML w poor outcomes. Ho…
RT @ColemanLindsley: Our latest in @BCD_AACR BCOR-PRC1.1 mutations are common in #leukemia and linked to secondary AML w poor outcomes. Ho…
Our latest in @BCD_AACR BCOR-PRC1.1 mutations are common in #leukemia and linked to secondary AML w poor outcomes. How do they work? @EvaJohannaScha1 defined their impact on complex assembly, chromatin localization, gene regulation, and TKI sensitivity
BCOR and BCORL1 mutations drive epigenetic reprogramming and oncogenic signaling by unlinking PRC1.1 from target genes https://t.co/yCmo4vDOz7
BCOR and BCORL1 mutations drive epigenetic reprogramming and oncogenic signaling by un-linking PRC1.1 from its target genes https://t.co/p4uC71xjKt
RT @BCD_AACR: Just published #OnlineFirst: BCOR and BCORL1 mutations drive epigenetic reprogramming and oncogenic signaling by unlinking PR…
RT @BCD_AACR: Just published #OnlineFirst: BCOR and BCORL1 mutations drive epigenetic reprogramming and oncogenic signaling by unlinking PR…
RT @BCD_AACR: Just published #OnlineFirst: BCOR and BCORL1 mutations drive epigenetic reprogramming and oncogenic signaling by unlinking PR…
RT @BCD_AACR: Just published #OnlineFirst: BCOR and BCORL1 mutations drive epigenetic reprogramming and oncogenic signaling by unlinking PR…
RT @BCD_AACR: Just published #OnlineFirst: BCOR and BCORL1 mutations drive epigenetic reprogramming and oncogenic signaling by unlinking PR…
RT @BCD_AACR: Just published #OnlineFirst: BCOR and BCORL1 mutations drive epigenetic reprogramming and oncogenic signaling by unlinking PR…
RT @BCD_AACR: Just published #OnlineFirst: BCOR and BCORL1 mutations drive epigenetic reprogramming and oncogenic signaling by unlinking PR…
Excited to share the work from my gap years and my first paper. Grateful to be part of the team and many thanks to @ColemanLindsley and Eva Schaefer for their incredible mentorship!
RT @BCD_AACR: Just published #OnlineFirst: BCOR and BCORL1 mutations drive epigenetic reprogramming and oncogenic signaling by unlinking PR…
RT @BCD_AACR: Just published #OnlineFirst: BCOR and BCORL1 mutations drive epigenetic reprogramming and oncogenic signaling by unlinking PR…
Just published #OnlineFirst: BCOR and BCORL1 mutations drive epigenetic reprogramming and oncogenic signaling by unlinking PRC1.1 from target genes. https://t.co/uQV5sUNlq9 @ColemanLindsley @DanaFarber #epigenetics #leusm